Physician

Kashif Firozvi, MD

According to 2025 Medicare claims, Kashif Firozvi, MD (NPI: 1568567618) practices medical oncology in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Montgomery, MD. This provider's primary affiliated billing organization is MARYLAND ONCOLOGY HEMATOLOGY, P.A. (NPI: 1821271032; TIN: 113652573) and primary practice location at 20904-7917.

Firozvi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 595 traditional Medicare patients, billed 159,685 HCPCS/CPT codes, and received $2,199,144 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 723 prescription claims across 132 beneficiaries totaling $3,382,993 in drug costs, led by Calquence (Acalabrutinib Maleate). 2022 DME data shows 30 claims. Open Payments data shows 86 records totaling $2,319. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $751,372 to $3,382,993. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,341 to $3,045.